CoChat

Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting

Open access

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background: American Diabetes Association (ADA) guidelines recommend a basal bolus correction insulin regimen as the preferred method of treatment for non–critically ill hospitalized patients. However, achieving ADA glucose targets safely, without hypoglycemia, is challenging. In this study we evaluated the safety and efficacy of basal bolus subcutaneous (SubQ) insulin therapy managed by providers compared to a nurse-directed Electronic Glycemic Management System (eGMS). Method: This retrospective crossover study evaluated 993 non-ICU patients treated with subcutaneous basal bolus insulin therapy managed by a provider compared to an eGMS. Analysis compared therapy outcomes before Glucommander (BGM), during Glucommander (DGM), and after Glucommander (AGM) for all patients. The blood glucose (BG) target was set at 140-180 mg/dL for all groups. The safety of each was evaluated by the following: (1) BG averages, (2) hypoglycemic events <40 and <70 mg/dL, and (3) percentage of BG in target. Result: Percentage of BG in target was BGM 47%, DGM 62%, and AGM 36%. Patients’ BGM BG average was 195 mg/dL, DGM BG average was 169 mg/dL, and AGM BG average was 174 mg/dL. Percentage of hypoglycemic events <70 mg/dL was 2.6% BGM, 1.9% DGM, and 2.8% AGM treatment. Conclusion: Patients using eGMS in the DGM group achieved improved glycemic control with lower incidence of hypoglycemia (<40 mg/dL and <70 mg/dl) compared to both BGM and AGM management with standard treatment. These results suggest that an eGMS can safely maintain glucose control with less hypoglycemia than basal bolus treatment managed by a provider.

Overview

Integrity signals

Registry

Crossref · 10.1177/1932296816664746

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Research works printed but not linked: 7

  1. Tanenberg R., 2013, Paper presented at: 73rd ADA Scientific Sessions
  2. Davidson P, 2012, Paper presented at: AACE
  3. Mabrey M, 2015, Paper presented at: AACE
  4. Aloi J, 2015, Paper presented at: AACE
  5. Aloi J, 2015, Paper presented at: ADA
  6. Ullal J, 2015, Paper presented at: DTM
  7. Mabrey M, 2015, Paper presented at: IHDM

Cited by

See all 39

Metadata

Authors
Aloi, J., Bode, B. W., Ullal, J., Chidester, P., McFarland, R. S., Bedingfield, A. E., Mabrey, M., Booth, R., Mumpower, A., & Wallia, A.
Affiliations
  • Wake Forest University Health Sciences (US)
  • Atlanta Diabetes Associates (US)
  • Eastern Virginia Medical School (US)
  • Sentara Health, Norfolk, VA, USA
  • Glytec, Waltham, MA, USA
  • Mountain States Health Alliance, Johnson City, TN, USA
  • Northwestern University (US)
Corresponding author
Aloi, Joseph
Venue
Journal of Diabetes Science and Technology
Published
2016-09-25
Volume
11
Issue
1
Pages
12-16
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2508448858
Cited by
39
References
19
Citations by year
2026: 4 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 1
FWCI
5.02
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
multiple daily insulin injections, subcutaneous insulin, hospitalized patients, glycemic control, hypoglycemia, blood glucose monitoring, diabetes management
MeSH terms
Adult, Aged, Algorithms, Blood Glucose, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Inpatients, Insulin, Insulin Infusion Systems, Male, Middle Aged, Retrospective Studies, Incidence, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting. https://app.cochat.ai/papers/10.1177/1932296816664746
The paper
Aloi, J., Bode, B. W., Ullal, J., Chidester, P., McFarland, R. S., Bedingfield, A. E., Mabrey, M., Booth, R., Mumpower, A., & Wallia, A. (2017). Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296816664746

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.